Literature DB >> 17586091

Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis.

Stefano Ghio1, Stefano Perlini, Giovanni Palladini, Nina Ajmone Marsan, Giovanna Faggiano, Monia Vezzoli, Catherine Klersy, Carlo Campana, Giampaolo Merlini, Luigi Tavazzi.   

Abstract

BACKGROUND: Patients with AL amyloidosis often present with signs of congestive heart failure. AIM: This study was prospectively designed to assess the significance of RV dysfunction in AL amyloidosis. METHODS AND
RESULTS: Seventy-four patients with biopsy proven AL amyloidosis underwent a thorough echocardiographic evaluation. A tricuspid annular plane systolic excursion (TAPSE)<17 mm was taken as marker of RV dysfunction. Plasma NT-proBNP determinations were performed in all cases. RV function was normal in 60 patients and reduced in 14 patients. Patients with RV dysfunction had thicker left ventricular (LV) walls (p<0.01), lower LV end-diastolic volumes (p<0.01), lower LV ejection fraction (p<0.01) and more frequently a restrictive LV filling pattern (p<0.01). RV dimensions and RV free wall thickness were not significantly different in the two groups. A thick interventricular septum and a reduced TAPSE were associated with high NT-proBNP levels (both p<0.01). Seven patients died during a median follow-up period of 19 months; TAPSE<17 mm was the only echocardiographic parameter associated with poor survival.
CONCLUSION: In patients with AL amyloidosis, RV dysfunction is associated with more severe involvement of the left ventricle, higher plasma levels of NT-proBNP and with poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586091     DOI: 10.1016/j.ejheart.2007.05.006

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

1.  Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis.

Authors:  Roberta Mussinelli; Francesco Salinaro; Alessio Alogna; Michele Boldrini; Ambra Raimondi; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

2.  Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.

Authors:  Nobutaka Nagano; Toshiyuki Yano; Yugo Fujita; Hidemichi Kouzu; Masayuki Koyama; Hiroshi Ikeda; Kenji Yasui; Atsuko Muranaka; Ryo Nishikawa; Ryo Takahashi; Naohiro Kishiue; Satoshi Yuda; Tetsuji Miura
Journal:  Heart Vessels       Date:  2019-09-26       Impact factor: 2.037

Review 3.  New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors:  Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal:  Curr Heart Fail Rep       Date:  2016-12

Review 4.  Cardiac amyloidosis: the heart of the matter.

Authors:  Federico Perfetto; Francesco Cappelli; Franco Bergesio; Gabriele Ciuti; Maria Cristina Porciani; Luigi Padeletti; Alberto Moggi Pignone
Journal:  Intern Emerg Med       Date:  2011-07-08       Impact factor: 3.397

5.  Prevalence and prognostic value of conduction disturbances at the time of diagnosis of cardiac AL amyloidosis.

Authors:  Michele Boldrini; Francesco Salinaro; Roberta Mussinelli; Ambra Raimondi; Alessio Alogna; Francesco Musca; Giovanni Palladini; Giampaolo Merlini; Stefano Perlini
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

Review 6.  Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.

Authors:  James A White; Nowell M Fine
Journal:  Curr Cardiol Rep       Date:  2016-08       Impact factor: 2.931

7.  The prognostic value of right ventricular deformation derived from cardiac magnetic resonance tissue tracking for all-cause mortality in light-chain amyloidosis patients.

Authors:  Hui Liu; Hang Fu; Ying-Kun Guo; Zhi-Gang Yang; Hua-Yan Xu; Xiao Shuai; Rong Xu; Zhen-Lin Li; Chun-Chao Xia; Yong He; Xiao-Yue Zhou
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

8.  Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.

Authors:  Ke Wan; Jiayu Sun; Yuchi Han; Yong Luo; Hong Liu; Dan Yang; Wei Cheng; Qing Zhang; Zhi Zeng; Yucheng Chen
Journal:  Heart Vessels       Date:  2017-08-24       Impact factor: 2.037

9.  Prognostic significance of right ventricular hypertrophy and systolic function in Anderson-Fabry disease.

Authors:  Francesca Graziani; Rosa Lillo; Elena Panaioli; Maurizio Pieroni; Antonia Camporeale; Elena Verrecchia; Ludovico Luca Sicignano; Raffaele Manna; Antonella Lombardo; Gaetano Antonio Lanza; Filippo Crea
Journal:  ESC Heart Fail       Date:  2020-05-20

10.  Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis.

Authors:  Jeremy Slivnick; Karolina M Zareba; Juliet Varghese; Vien Truong; Alexander L Wallner; Matthew S Tong; Christopher Hummel; Wojciech Mazur; Saurabh Rajpal
Journal:  Open Heart       Date:  2022-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.